Healx

Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.

Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.

Healx headquartered in Europe, operates in the Biotechnology, Artificial Intelligence (AI), Health Care, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $16.1B in funding across 140 round(s). With a team of 51-100 employees, Healx is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Healx, raised $1.9M. Discover more about their projects, partnerships, and impact on our platform.